{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:04:27Z","timestamp":1790798667167,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"am","delay-in-days":332,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016650","name":"RDCRN","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016650","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ymgme.2025.109195","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T15:06:59Z","timestamp":1752937619000},"page":"109195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Predicting disease-overarching therapeutic approaches for congenital disorders of glycosylation using multi-OMICS"],"prefix":"10.1016","volume":"146","author":[{"given":"I.J.J.","family":"Muffels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Budhraja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Radenkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Morava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Kozicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ymgme.2025.109195_bb0005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1254\/jjp.30.29","article-title":"The action of chlorphenesin carbamate on the frog spinal cord","volume":"30","author":"Aihara","year":"1980","journal-title":"Jpn. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109195_bb0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0304-4165(99)00165-8","article-title":"On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database","volume":"1473","author":"Apweiler","year":"1999","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"15","key":"10.1016\/j.ymgme.2025.109195_bb0015","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.202400012","article-title":"Dysregulated proteome and N-glycoproteome in ALG1-deficient fibroblasts","volume":"24","author":"Budhraja","year":"2024","journal-title":"Proteomics"},{"issue":"2","key":"10.1016\/j.ymgme.2025.109195_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.108487","article-title":"Liposome-encapsulated mannose-1-phosphate therapy improves global N-glycosylation in different congenital disorders of glycosylation","volume":"142","author":"Budhraja","year":"2024","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109195_bb0025","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/jimd.12557","article-title":"N-glycoproteomics reveals distinct glycosylation alterations in <scp>NGLY1<\/scp> \u2212deficient patient-derived dermal fibroblasts","volume":"46","author":"Budhraja","year":"2023","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2025.109195_bb0030","series-title":"A drug repurposing screen identifies NSAIDs and COX1\/2 enzyme inhibition as potential therapies for MAN1B1-CDG, a rare congenital disorder of glycosylation","first-page":"168","author":"Chow","year":"2024"},{"issue":"10","key":"10.1016\/j.ymgme.2025.109195_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1011458","article-title":"A drug repurposing screen reveals dopamine signaling as a critical pathway underlying potential therapeutics for the rare disease DPAGT1-CDG","volume":"20","author":"Dalton","year":"2024","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ymgme.2025.109195_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.869031","article-title":"Evaluation of cell models to study monocyte functions in PMM2 congenital disorders of glycosylation","volume":"13","author":"de Haas","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymgme.2025.109195_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177602","article-title":"Chrysin\u2019s anti-inflammatory action in the central nervous system: a scoping review and an evidence-gap mapping of its mechanisms","volume":"997","author":"Del Fabbro","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ymgme.2025.109195_bb0050","series-title":"Essentials of Glycobiology (4th Edition)","author":"Gagneux","year":"2022"},{"issue":"5","key":"10.1016\/j.ymgme.2025.109195_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167163","article-title":"Transcriptomic analysis identifies dysregulated pathways and therapeutic targets in PMM2-CDG","volume":"1870","author":"Gallego","year":"2024","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"11","key":"10.1016\/j.ymgme.2025.109195_bb0060","doi-asserted-by":"crossref","DOI":"10.1093\/glycob\/cwae076","article-title":"N-glycoproteomic and proteomic alterations in SRD5A3-deficient fibroblasts","volume":"34","author":"Garapati","year":"2024","journal-title":"Glycobiology"},{"key":"10.1016\/j.ymgme.2025.109195_bb0065","series-title":"Mannose-1-Phosphate Replacement Therapy: A Potential Treatment for PMM2-CDG","author":"Glycomine","year":"2022"},{"issue":"2","key":"10.1016\/j.ymgme.2025.109195_bb0070","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ymgme.2015.09.012","article-title":"A beta-blocker, propranolol, decreases the efficacy from enzyme replacement therapy in Pompe disease","volume":"117","author":"Han","year":"2016","journal-title":"Mol. Genet. Metab."},{"issue":"D1","key":"10.1016\/j.ymgme.2025.109195_bb0075","doi-asserted-by":"crossref","first-page":"D1214","DOI":"10.1093\/nar\/gkv1031","article-title":"ChEBI in 2016: improved services and an expanding collection of metabolites","volume":"44","author":"Hastings","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/j.ymgme.2025.109195_bb0080","article-title":"Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG","volume":"12","author":"Iyer","year":"2019","journal-title":"DMM Dis. Models Mech."},{"issue":"5795","key":"10.1016\/j.ymgme.2025.109195_bb0085","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ymgme.2025.109195_bb0090","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1534\/g3.118.200934","article-title":"Yeast models of phosphomannomutase 2 deficiency, a congenital disorder of glycosylation","volume":"9","author":"Lao","year":"2019","journal-title":"G3 (Bethesda, Md.)"},{"key":"10.1016\/j.ymgme.2025.109195_bb0095","series-title":"Essentials of Glycobiology","article-title":"Congenital disorders of glycosylation","author":"Lefeber","year":"2022"},{"issue":"8","key":"10.1016\/j.ymgme.2025.109195_bb0100","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.3390\/genes14081585","article-title":"Interplay of impaired cellular bioenergetics and autophagy in PMM2-CDG","volume":"14","author":"Ligezka","year":"2023","journal-title":"Genes"},{"issue":"6","key":"10.1016\/j.ymgme.2025.109195_bb0105","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/ana.26245","article-title":"Sorbitol is a severity biomarker for PMM2-CDG with therapeutic implications","volume":"90","author":"Ligezka","year":"2021","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.ymgme.2025.109195_bb0110","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1086\/510023","article-title":"Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations","volume":"79","author":"L\u00f3pez","year":"2006","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109195_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.70011","article-title":"The therapeutic future for congenital disorders of glycosylation","volume":"48","author":"Muffels","year":"2025","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109195_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.108476","article-title":"Clinical and biochemical footprints of congenital disorders of glycosylation: proposed nosology","volume":"142","author":"Ng","year":"2024","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109195_bb0125","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/jimd.12237","article-title":"Severe phenotype of <scp>ATP6AP1-CDG<\/scp> in two siblings with a novel mutation leading to a differential tissue-specific <scp>ATP6AP1<\/scp> protein pattern, cellular oxidative stress and hepatic copper accumulation","volume":"43","author":"Ondruskova","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109195_bb0130","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/glycob\/cwab087","article-title":"Dissecting the transcriptional program of phosphomannomutase 2-deficient cells: Lymphoblastoide B cell lines as a valuable model for congenital disorders of glycosylation studies","volume":"32","author":"Parrado","year":"2022","journal-title":"Glycobiology"},{"issue":"3","key":"10.1016\/j.ymgme.2025.109195_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113883","article-title":"Neural and metabolic dysregulation in PMM2-deficient human in vitro neural models","volume":"43","author":"Radenkovic","year":"2024","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.ymgme.2025.109195_bb0140","article-title":"Tracer metabolomics reveals the role of aldose reductase in glycosylation","volume":"4","author":"Radenkovic","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.ymgme.2025.109195_bb0145","series-title":"PGM1 Deficiency Disrupts Sarcomere and Mitochondrial Function in a Stem-Cell Cardiomyocyte Model","author":"Radenkovic","year":"2025"},{"issue":"5","key":"10.1016\/j.ymgme.2025.109195_bb0150","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s11745-997-0064-6","article-title":"Effect of docosahexaenoic acid on mouse mitochondrial membrane properties","volume":"32","author":"Stillwell","year":"1997","journal-title":"Lipids"},{"key":"10.1016\/j.ymgme.2025.109195_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.140865","article-title":"Cysteine variants in PMM2 lead to protein instability and higher sensitivity to oxidative stress in PMM2-CDG","volume":"305","author":"Sun","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109195_bb0160","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41436-019-0647-2","article-title":"Therapeutic approaches in congenital disorders of glycosylation (CDG) involving N-linked glycosylation: an update","volume":"22","author":"Verheijen","year":"2020","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2025.109195_bb0165","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jare.2023.09.002","article-title":"Plasma glycoproteomics delivers high-specificity disease biomarkers by detecting site-specific glycosylation abnormalities","volume":"61","author":"Wessels","year":"2024","journal-title":"J. Adv. Res."},{"issue":"Database issue","key":"10.1016\/j.ymgme.2025.109195_bb0170","doi-asserted-by":"crossref","first-page":"D668","DOI":"10.1093\/nar\/gkj067","article-title":"DrugBank: a comprehensive resource for in silico drug discovery and exploration","volume":"34","author":"Wishart","year":"2006","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109195_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107629","article-title":"Metabolic adaptation of human skin fibroblasts to ER stress caused by glycosylation defect in PMM2-CDG","volume":"139","author":"Zdrazilova","year":"2023","journal-title":"Mol. Genet. Metab."},{"issue":"18","key":"10.1016\/j.ymgme.2025.109195_bb0180","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1093\/bioinformatics\/bty325","article-title":"EMUDRA: Ensemble of Multiple Drug Repositioning Approaches to improve prediction accuracy","volume":"34","author":"Zhou","year":"2018","journal-title":"Bioinformatics"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225001866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225001866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T23:02:23Z","timestamp":1761433343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719225001866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":36,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1096719225001866"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109195","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.07.07.663468","asserted-by":"object"}]},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting disease-overarching therapeutic approaches for congenital disorders of glycosylation using multi-OMICS","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109195","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109195"}}